Wang W, Russell A, Yan Y. Traditional Chinese medicine and new concepts of predictive, preventive and personalized medicine in diagnosis and treatment of suboptimal health. EPMA J. 2014;5(1):4. https://doi.org/10.1186/1878-5085-5-4.
Article PubMed PubMed Central Google Scholar
Wang W, Yan Y. Suboptimal health: a new health dimension for translational medicine. Clin Transl Med. 2012;1(1):28. https://doi.org/10.1186/2001-1326-1-28.
Article PubMed PubMed Central Google Scholar
Wang W, Yan Y, Guo Z, Hou H, Garcia M, Tan X, et al. All around suboptimal health - a joint position paper of the Suboptimal Health Study Consortium and European Association for Predictive, Preventive and Personalised Medicine. Epma J. 2021;12(4):403–433. https://doi.org/10.1007/s13167-021-00253-2.
NCD Countdown 2030 collaborators. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. Lancet. 2018;392(10152):1072–1088. https://doi.org/10.1016/s0140-6736(18)31992-5.
Ezzati M, Pearson-Stuttard J, Bennett JE, Mathers CD. Acting on non-communicable diseases in low- and middle-income tropical countries. Nature. 2018;559(7715):507–16. https://doi.org/10.1038/s41586-018-0306-9.
CAS Article PubMed Google Scholar
Nugent R. Preventing and managing chronic diseases. BMJ. 2019;364:l459. https://doi.org/10.1136/bmj.l459.
Wang H, Tian Q, Zhang J, Liu H, Zhang X, Cao W, et al. Population-based case-control study revealed metabolomic biomarkers of suboptimal health status in Chinese population-potential utility for innovative approach by predictive, preventive, and personalized medicine. EPMA J. 2020;11(2):147–60. https://doi.org/10.1007/s13167-020-00200-7.
CAS Article PubMed PubMed Central Google Scholar
Yan YX, Dong J, Liu YQ, Yang XH, Li M, Shia G, et al. Association of suboptimal health status and cardiovascular risk factors in urban Chinese workers. J Urban Health. 2012;89(2):329–38. https://doi.org/10.1007/s11524-011-9636-8.
Golubnitschaja O, Kinkorova J, Costigliola V. Predictive, preventive and personalised medicine as the hardcore of ‘Horizon 2020’: EPMA position paper. EPMA J. 2014;5(1):6. https://doi.org/10.1186/1878-5085-5-6.
Article PubMed PubMed Central Google Scholar
Wang Y, Liu X, Qiu J, Wang H, Liu D, Zhao Z, et al. Association between ideal cardiovascular health metrics and suboptimal health status in Chinese population. Sci Rep. 2017;7(1):14975. https://doi.org/10.1038/s41598-017-15101-5.
CAS Article PubMed PubMed Central Google Scholar
Ge S, Xu X, Zhang J, Hou H, Wang H, Liu D, et al. Suboptimal health status as an independent risk factor for type 2 diabetes mellitus in a community-based cohort: the China suboptimal health cohort study. EPMA J. 2019;10(1):65–72. https://doi.org/10.1007/s13167-019-0159-9.
Article PubMed PubMed Central Google Scholar
Alzain MA, Asweto CO, Zhang J, Fang H, Zhao Z, Guo X, et al. Telomere length and accelerated biological aging in the China suboptimal health cohort: a case-control study. OMICS. 2017;21(6):333–9. https://doi.org/10.1089/omi.2017.0050.
CAS Article PubMed Google Scholar
Sun Q, Xu X, Zhang J, Sun M, Tian Q, Li Q, et al. Association of suboptimal health status with intestinal microbiota in Chinese youths. J Cell Mol Med. 2020;24(2):1837–47. https://doi.org/10.1111/jcmm.14880.
CAS Article PubMed Google Scholar
Wang H, Tian Q, Zhang J, Liu H, Zhang J, Cao W, et al. Blood transcriptome profiling as potential biomarkers of suboptimal health status: potential utility of novel biomarkers for predictive, preventive, and personalized medicine strategy. EPMA J. 2021;12(2):103–15. https://doi.org/10.1007/s13167-021-00238-1.
Gornik O, Pavic T, Lauc G. Alternative glycosylation modulates function of IgG and other proteins - implications on evolution and disease. Biochim Biophys Acta. 2012;1820(9):1318–26. https://doi.org/10.1016/j.bbagen.2011.12.004.
CAS Article PubMed Google Scholar
Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease. Cell. 2006;126(5):855–67. https://doi.org/10.1016/j.cell.2006.08.019.
CAS Article PubMed PubMed Central Google Scholar
Dalziel M, Crispin M, Scanlan CN, Zitzmann N, Dwek RA. Emerging principles for the therapeutic exploitation of glycosylation. Science. 2014;343(6166):1235681. https://doi.org/10.1126/science.1235681.
CAS Article PubMed Google Scholar
Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5:520. https://doi.org/10.3389/fimmu.2014.00520.
CAS Article PubMed PubMed Central Google Scholar
Reily C, Stewart TJ, Renfrow MB, Novak J. Glycosylation in health and disease. Nat Rev Nephrol. 2019;15(6):346–66. https://doi.org/10.1038/s41581-019-0129-4.
Article PubMed PubMed Central Google Scholar
Sondermann P, Pincetic A, Maamary J, Lammens K, Ravetch JV. General mechanism for modulating immunoglobulin effector function. Proc Natl Acad Sci U S A. 2013;110(24):9868–72. https://doi.org/10.1073/pnas.1307864110.
Article PubMed PubMed Central Google Scholar
Li T, DiLillo DJ, Bournazos S, Giddens JP, Ravetch JV, Wang LX. Modulating IgG effector function by Fc glycan engineering. Proc Natl Acad Sci U S A. 2017;114(13):3485–90. https://doi.org/10.1073/pnas.1702173114.
CAS Article PubMed PubMed Central Google Scholar
Gornik O, Wagner J, Pucic M, Knezevic A, Redzic I, Lauc G. Stability of N-glycan profiles in human plasma. Glycobiology. 2009;19(12):1547–53. https://doi.org/10.1093/glycob/cwp134.
CAS Article PubMed Google Scholar
Yu X, Wang Y, Kristic J, Dong J, Chu X, Ge S, et al. Profiling IgG N-glycans as potential biomarker of chronological and biological ages: a community-based study in a Han Chinese population. Medicine (Baltimore). 2016;95(28):e4112. https://doi.org/10.1097/md.0000000000004112.
Wang Y, Klarić L, Yu X, Thaqi K, Dong J, Novokmet M, et al. The Association between glycosylation of immunoglobulin G and hypertension: a multiple ethnic cross-sectional study. Medicine (Baltimore). 2016;95(17):e3379. https://doi.org/10.1097/md.0000000000003379.
Liu D, Li Q, Dong J, Li D, Xu X, Xing W, et al. The association between normal BMI with central adiposity and proinflammatory potential immunoglobulin G N-glycosylation. Diabetes Metab Syndr Obes. 2019;12:2373–85. https://doi.org/10.2147/dmso.S216318.
CAS Article PubMed PubMed Central Google Scholar
Liu D, Zhao Z, Wang A, Ge S, Wang H, Zhang X, et al. Ischemic stroke is associated with the pro-inflammatory potential of N-glycosylated immunoglobulin G. J Neuroinflammation. 2018;15(1):123. https://doi.org/10.1186/s12974-018-1161-1.
CAS Article PubMed PubMed Central Google Scholar
Lemmers RFH, Vilaj M, Urda D, Agakov F, Šimurina M, Klaric L, et al. IgG glycan patterns are associated with type 2 diabetes in independent European populations. Biochim Biophys Acta Gen Subj. 2017;1861(9):2240–9. https://doi.org/10.1016/j.bbagen.2017.06.020.
CAS Article PubMed Google Scholar
Greto VL, Cvetko A, Štambuk T, Dempster NJ, Kifer D, Deriš H, et al. Extensive weight loss reduces glycan age by altering IgG N-glycosylation. Int J Obes (Lond). 2021;45(7):1521–31. https://doi.org/10.1038/s41366-021-00816-3.
Yan YX, Liu YQ, Li M, Hu PF, Guo AM, Yang XH, et al. Development and evaluation of a questionnaire for measuring suboptimal health status in urban Chinese. J Epidemiol. 2009;19(6):333–41. https://doi.org/10.2188/jea.je20080086.
Article PubMed PubMed Central Google Scholar
Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95. https://doi.org/10.1249/01.Mss.0000078924.61453.Fb.
Bagby RM, Ryder AG, Schuller DR, Marshall MB. The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry. 2004;161(12):2163–77. https://doi.org/10.1176/appi.ajp.161.12.2163.
Liu D, Xu X, Li Y, Zhang J, Zhang X, Li Q, et al. Immunoglobulin G N-glycan analysis by ultra-performance liquid chromatography. J Vis Exp. 2020;(155):e60104. https://doi.org/10.3791/60104.
Wang H, Li X, Wang X, Liu D, Zhang X, Cao W, et al. Next-generation (glycomic) biomarkers for cardiometabolic health: a community-based study of immunoglobulin G N-glycans in a Chinese Han population. OMICS. 2019;23(12):649–59. https://doi.org/10.1089/omi.2019.0099.
CAS Article PubMed Google Scholar
Zhang X, Yuan H, Lyu J, Meng X, Tian Q, Li Y, et al. Association of dementia with immunoglobulin G N-glycans in a Chinese Han population. NPJ Aging Mech Dis. 2021;7(1):3. https://doi.org/10.1038/s41514-021-00055-w.
CAS Article PubMed PubMed Central Google Scholar
Liu D, Chu X, Wang H, Dong J, Ge SQ, Zhao ZY, et al. The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia. J Transl Med. 2018;16(1):235. https://doi.org/10.1186/s12967-018-1616-2.
CAS Article PubMed PubMed Central Google Scholar
Maverakis E, Kim K, Shimoda M, Gershwin ME, Patel F, Wilken R, et al. Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review. J Autoimmun. 2015;57:1–13. https://doi.org/10.1016/j.jaut.2014.12.002.
CAS Article PubMed Google Scholar
Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med. 1995;1(3):237–43. https://doi.org/10.1038/nm0395-237.
CAS Article PubMed Google Scholar
Mihai S, Nimmerjahn F. The role of Fc receptors and complement in autoimmunity. Autoimmun Rev. 2013;12(6):657–60. https://doi.org/10.1016/j.autrev.2012.10.008.
CAS Article PubMed Google Scholar
Karsten CM, Pandey MK, Figge J, Kilchenstein R, Taylor PR, Rosas M, et al. Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1. Nat Med. 2012;18(9):1401–6. https://doi.org/10.1038/nm.2862.
留言 (0)